iphepha-banner

iindaba

Ukukhuthazwa koMnqongo kunokunciphisa ukusetyenziswa kweOpioid

Ukusetyenziswa kwe-opioid yizigulane ezineentlungu ezingapheliyo mhlawumbi zehla okanye zizinzile emva kokuba zifumene isixhobo sokuvuselela intambo yomgogodla, ngokutsho kophando olutsha.

Iziphumo zabangela ukuba abaphandi bacebise ukuba oogqirha bacinge ngokuvuselela intambo yomgogodla (SCS) ngokukhawuleza kwizigulane ezinentlungu ebuhlungu ngaphezu kwexesha kunokumisela i-painkillers, utshilo umphandi oyintloko u-Ashwini Sharan, MD, ngodliwano-ndlebe.Abathumeli abancinci, abanamandla ebhetri bahambisa imiqondiso ngemikhombandlela yombane emiliselwe ecaleni kwentambo yomqolo ukuphazamisa imiyalezo yeentlungu ezihamba ukusuka kwimithambo-luvo ukuya ebuchotsheni.

Uphononongo lubandakanya idatha ye-inshurensi evela kwizigulane ze-5476 ezine-SCS kwaye zithelekisa amanani emimiselo yazo ye-opioid ngaphambi nangemva kokufakwa.Kunyaka omnye emva kokufakelwa, i-93% yezigulane eziye zaqhubeka nonyango lwe-spinal cord stimulation (SCS) zinemilinganiselo ephantsi ye-morphine-equivalent yemihla ngemihla kunezigulane eziye zasuswa inkqubo yazo ye-SCS, ngokutsho kophononongo, apho uSharan uceba ukuhambisa ukupapashwa.

"Into esiyiqapheleyo kukuba abantu babenokwenyuka okukhulu ekusebenziseni kwabo i-narcotic kunyaka ngaphambi kokufakelwa," utshilo uSharan, unjingalwazi we-neurosurgery kwiYunivesithi yaseThomas Jefferson ePhiladelphia kunye nomongameli weNorth American Neuromodulation Society.USharan ubonise iziphumo kwintlanganiso yonyaka yeqela kule veki.” Kwiqela elaqhubeka ne-SCS, ithamo le-narcotic liye lehliswa kwakhona ukuya kwinqanaba elalikulo ngaphambi kokuba linyuke.

Umnqonqo

"Akukho datha eninzi yabemi, ngokusisiseko, ithi yintoni ubudlelwane phakathi kwezi narcotics kunye nezi zihlohli. Yiyo ngokwenene i-punchline yale nto, "wongezelela. "Sinoxwebhu olusebenzayo kunye neprotocol kwaye sixhasa uphononongo oluzayo. yokusebenzisa isixhobo njengesicwangciso sokunciphisa i-narcotic kuba ukholelwa okanye hayi, engakhange ifundwe."

Abaphandi babengazi ukuba zeziphi iinkqubo ze-SCS zabavelisi ezifakwe kwizigulane eziye zafunda idatha yazo, kwaye zingenayo inkxaso-mali elungiselelwe uphando olongezelelweyo, ngokutsho kukaSharan.Uphononongo lokuqala lwaxhaswa ngemali yiSt. Jude Medical, esanda kufunyanwa ngu-Abbott.I-FDA ivume inkqubo ye-St. Jude's BurstDR SCS ngo-Okthobha ophelileyo, yamva nje kuthotho lwemvume ye-SCS.

U-Abbott waya kubude obude ukucenga oogqirha ukuba bamisele i-opioid painkiller i-OxyContin kwiminyaka yokuqala yokufumaneka kwayo, ngokwengxelo ye-STAT News.Umbutho weendaba ufumene iirekhodi kwityala eliziswe ngurhulumente waseWest Virginia ngokuchasene no-Abbott kunye nomphuhlisi we-OxyContin uPurdue Pharma LP, etyhola ukuba bathengisa ichiza ngokungafanelekanga.I-Purdue yahlawula i-10 yezigidi zeedola ngo-2004 ukulungisa ityala.Akukho nanye inkampani, evumileyo ukukhuthaza i-OxyContin, evumileyo ukwenza ububi.

"I-SCS sisigqibo sokugqibela," waqhubeka uSharan."Ukuba ulinda unyaka ukuba umntu aphantse aphinde kabini idosi yakhe ye-narcotic, ngoko kufuneka umlumle kuloo nto. Lixesha elininzi elilahlekileyo."

Ummiselo wonyaka we-morphine ubiza i-5,000 yeedola, kwaye iindleko zeziphumo ebezingalindelekanga zongeza kwitotali, uSharan waqaphela.I-Spinal cord stimulators zibiza umyinge we-16,957 yeedola ngoJanuwari 2015, i-8% ukusuka kunyaka odlulileyo, ngokwe-Modern Healthcare / ECRI Institute Technology Price Index.Imodeli emitsha, entsokothileyo eyenziwe yiBoston Scientific kunye neMedtronic ixabisa i-avareji ye-19,000 yeedola, ukusuka malunga ne-13,000 yeedola kwiimodeli ezindala, umboniso wedatha we-ECRI.

Izibhedlele zikhetha iimodeli ezintsha, i-ECRI ibike, nangona uhlaziyo olufana noxhumano lweBluetooth alwenzi nto ukuphucula intlungu, ngokutsho kukaSharan.Umongameli woluntu uthe ufaka malunga nezixhobo ze-300 ngonyaka, kuquka i-SCS, kwaye uzama ukwenza "umahluko omkhulu, xa ndithetha noogqirha, kwiimpawu ezichasene nomsebenzi. Abantu bayalahleka ngokwenene kwizixhobo ezitsha ezikhanyayo."


Ixesha lokuthumela: Jan-27-2017